75 breakthrough innovations and our simplest workflow yet
Kits & Reagents
Rapid library preparation from a broad range of sample types for studying the coding and non-coding transcriptome with unparalleled study flexibility
Selection & Planning Tools
Compare instruments and find one that's right for you
Software & Informatics Products
Pay-as-you-go or purchase larger quantities at a lower price point for high-throughput data analysis applications
Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing
Find popular product groupings for your workflow
Whole-genome shotgun sequencing and transcriptomics provide data to refine drug discovery and development
Love and care is never rare
All Investor Information
After a shutdown: best practices to ensure a successful reopening
All Support Tools
Product Support Services
Expanded portfolio enables comprehensive genomic profiling from blood and tissue
Cancer Research Products
Microbial Genomics Research
Whole-genome sequencing using NGS technology delivers comprehensive genetic analysis
Microbial Genomics Products
A highly sensitive and accurate tool for measuring expression across the transcriptome
Powerful tools for studying the transcriptome in an unbiased manner from minimal input
Complex Disease Research Products
How cfDNA affects test results when considering NIPT
Reproductive Health Products
Genetic Health Products
Access a variety of NGS and array educational resources for clinical cancer research, including assorted videos and scientific papers.
Dr. Rahman reviews characteristics of known cancer predisposition genes and the potential prospects of future discoveries.
Nature Genetics presents the iCOGS Focus, which comprises a collection of 13 papers by the COGS Consortium.
Sequencing melanoma-prone family identified disease-segregating germline mutation in promoter of telomerase reverse transcriptase gene.
Jackson et al. demonstrate the use of high-density arrays to identify copy number changes in pediatric rhabdoid tumors.
Ho et al. identify 3 distinct subtypes of orbital meningioma via genetic profiling with microarrays.
Harada et al. use arrays to detect deletions and copy-neutral loss of heterozygosity.
Dr. Riazalhosseini at McGill University preserves the integrity of FFPE samples to analyze disease-causing mutations.
Dr. Navin at MD Anderson Cancer Center uses single-cell sequencing to analyze heterogeneity in tumor subpopulations.
Dr. Trilochan Sahoo, Director of Cytogenetics at Combimatrix, discusses array-based cytogenetic analysis for cancer.
Scientists at Cancer Genetics, Inc discuss how targeted NGS helps identify myeloid-related genes with greater sensitivity.
Deep analysis of exosomal DNA found in the blood of pancreatic cancer subjects offers insight into the potential of liquid biopsies.
A new enrichment-based cancer research assay interrogates both DNA and RNA, detecting small variants, gene amplifications, gene fusions, and splice variants.
Dr. Fellowes at Peter MacCallum Cancer Centre discusses how his team uses Illumina technology.
Nicholas J. Schork, PhD speaks about whole human genome variation, cancer driver mutations, and clinical sequencing.
Luis Diaz, MD at Johns Hopkins School of Medicine discusses using NGS to analyze ovarian and endometrial cancers.
Learn how comprehensive tumor profiling with NGS can help you avoid costly and time-consuming iterative testing.
Kenneth Bloom, MD, FCAP, Chief Medical Officer at Clarient (GE Healthcare) discusses the practical aspects of applying NGS in clinical research.
Visit our Medical Genetics website to download an introduction to NGS technology and applications for molecular pathologists.
View educational resources from recognized oncology experts and regulatory bodies about applying NGS in a clinical research setting.
View educational resources from recognized oncology experts and regulatory bodies about applying NGS in a clinical setting.
This is the international website for Illumina. If you are looking for information specific to your region, please select your location and we will redirect you.